The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDoric Nimrod 3 Regulatory News (DNA3)

Share Price Information for Doric Nimrod 3 (DNA3)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.25
Bid: 51.50
Ask: 53.00
Change: 0.00 (0.00%)
Spread: 1.50 (2.913%)
Open: 53.00
High: 53.00
Low: 52.25
Prev. Close: 52.25
DNA3 Live PriceLast checked at -
Doric Nimrod Air Three is an Investment Trust

To obtain income returns and a capital return for its Shareholders by acquiring, leasing and then selling aircraft.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of the fourth aircraft

27 Nov 2013 17:30

RNS Number : 1193U
DNA Alpha
27 November 2013
 



NOT FOR DISTRIBUTION OR RELEASE IN ANY JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW

DORIC NIMROD AIR THREE LIMITED

DNA ALPHA LIMITED

Acquisition of the fourth aircraft

27 November 2013

 

Doric Nimrod Air Three Limited ("DNA3") and its wholly-owned subsidiary DNA Alpha Limited ("DNA Alpha") are pleased to announce that DNA Alpha, on 27 November 2013 purchased an Airbus A380-861 aircraft bearing manufacturer's serial number 133 (the "Aircraft") for the sum of US$245,000,000.

 

DNA Alpha also entered into an Aircraft Operating Lease Agreement with Emirates pursuant to which the Aircraft would be leased to Emirates.

 

This Aircraft is the fourth acquired by DNA Alpha and the final Airbus A380 aircraft to be acquired pursuant to the Initial Investment Process outlined in the DNA3 Prospectus dated 20 June 2013.

 

About the Company

DNA3 is a Guernsey domiciled company with shares admitted to the official list of the Channel Islands Stock Exchange and to trading on the Specialist Fund Market of the London Stock Exchange (LSE:DNA3).

DNA Alpha is a Guernsey domiciled company with pass through certificates admitted to listing on the Official List and trading on the Main Securities Market of the Irish Stock Exchange.

DNA3's investment objective is to obtain income returns and a capital return for its Shareholders by acquiring, leasing and then selling aircraft (the "Assets").

To pursue its investment objective, DNA3 will seek to use the net proceeds of placings and other equity capital raisings, together with debt facilities (or instruments), to initially acquire Airbus A380 aircraft which will be leased to one or more major airlines.

The Company aims to provide Shareholders with an attractive total return comprising income, from distributions through the period of the Company's ownership of the Assets, and capital, upon the sale of the Assets.

 

For further information, please contact:

For administrative and company information:

Anson Fund Managers Limited

+44 (0) 1481 722260

 

 For shareholder information:

Nimrod Capital LLP

Richard Bolchover

Marc Gordon

+44 (0) 20 3355 6855

 

E&OE - In Transmission

 

END OF ANNOUNCEMENT

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQFEUFWWFDSEFF
Date   Source Headline
5th Jul 20194:15 pmRNSQuarterly Report
11th Apr 20194:45 pmRNSDividend Declaration
11th Apr 20194:45 pmRNSQuarterly Report
13th Mar 20191:57 pmRNSHolding(s) in Company
19th Feb 20193:43 pmRNSHolding(s) in Company
14th Feb 20194:40 pmRNSStatement re AIRBUS A380 UPDATE
17th Jan 20192:30 pmRNSQuarterly Report
17th Jan 20192:00 pmRNSDividend Declaration
14th Nov 20184:50 pmRNSHalf-year Report
8th Nov 20184:46 pmRNSResult of AGM
11th Oct 20186:33 pmRNSNotice of AGM
10th Oct 20184:30 pmRNSDividend Declaration
10th Oct 20184:30 pmRNSQuarterly Report
11th Jul 20185:30 pmRNSQuarterly Report
11th Jul 20185:24 pmRNSDividend Declaration
11th Jul 20185:23 pmRNSAnnual Financial Report
12th Apr 20184:50 pmRNSQuarterly Report
12th Apr 20184:50 pmRNSDividend Declaration
6th Apr 20185:29 pmRNSHolding(s) in Company
27th Mar 20184:55 pmRNSDirectorate Change
11th Jan 20184:25 pmRNSDividend Declaration
11th Jan 20184:20 pmRNSQuarterly Report
14th Dec 20177:00 amRNSHalf-year Report
21st Nov 20174:47 pmRNSHolding(s) in Company
11th Oct 20173:45 pmRNSDividend Declaration
11th Oct 20173:45 pmRNSQuarterly Factsheet
15th Sep 20172:04 pmRNSResult of AGM
12th Jul 20173:44 pmRNSDividend Declaration
12th Jul 20173:40 pmRNSQuarterly Factsheet
10th Jul 20174:05 pmRNSAnnual Financial Report and Notice of AGM
11th Apr 20174:15 pmRNSQuarterly Factsheet
11th Apr 20174:15 pmRNSDividend Declaration
11th Jan 20175:00 pmRNSDividend Declaration
11th Jan 20175:00 pmRNSQuarterly Factsheet
3rd Jan 20173:50 pmRNSChange of Name of Secretary
1st Dec 20166:01 pmRNSHalf-year Report
12th Oct 20163:00 pmRNSDividend Declaration
12th Oct 20163:00 pmRNSQuarterly Fact Sheet
4th Oct 20163:44 pmRNSResults of AGM
12th Jul 20165:30 pmRNSAnnual Financial Report
12th Jul 20163:39 pmRNSQuarterly Factsheet
11th Jul 20166:15 pmRNSDividend Declaration
14th Apr 20164:40 pmRNSQuarterly Factsheet
14th Apr 20164:30 pmRNSDividend Declaration
25th Feb 20166:00 pmRNSDisclosure of Home Member State
8th Jan 20169:00 amRNSDirector's other directorship
6th Jan 20164:35 pmRNSQuarterly Factsheet
5th Jan 20162:00 pmRNSDividend Declaration
24th Nov 201512:00 pmRNSHalf Yearly Report
16th Nov 20158:00 amRNSChange of Registered Office

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.